Comment on EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources

BRUSSELS (Reuters) - EU antitrust regulators will widen a probe into Zimmer Holdings Inc's $13.4 billion bid for Biomet Inc [LVBHAB.UL] but clear Eli Lilly's offer for a Novartis AG unit, three people familiar with the matter said on Thursday.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News